A股異動丨江淮汽車(600418.SH)、國軒高科(002074.SZ)再度漲停 獲大眾入股
格隆匯6月1日丨江淮汽車(600418.SH)漲停,近9個交易日收穫7個漲停,現報9.97元,暫成交9.5億元,最新總市值188億元。國軒高科(002074.SZ)連續第二個交易日漲停,現報32.89元,暫成交782萬元,最新總市值371億元。當地時間29日,德國大眾汽車集團宣佈將在中國電動汽車領域投資約20億歐元。其中約10億獲得安徽江淮汽車集團控股50%的股份,同時增持江淮大眾汽車的股份至75%;另外約10億獲得電池製造商國軒高科近26.5%的股份,成為其最大股東。大眾在聲明中稱,上述兩項投資將為大眾在華業務開啟新的篇章奠定堅實基礎。


Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.